Page results
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Fiona Farrell works at the Sir William Gowers Unit, a specialist treatment centre for epilepsy and related disorders.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
UCLH has declared a climate and health emergency, and has published a 10-point climate action plan to reach net zero carbon dioxide emissions by 2031.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
File results
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0162 - ICT and Procurement strategy and organisational charts
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0174 - Integration Engine (IE) within Trust's IT estate
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0159 - Local treatment guidelines for Atopic Dermatitis (Atopic Eczema)
-
FOI/2023/0156 - Digital sepsis alerts for obstetric patients